CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Boston Scientific Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Boston Scientific Corporation
300 Boston Scientific Way
Phone: (508) 683-4000p:508 683-4000 MARLBOROUGH, MA  01752-1291  United States Ticker: BSXBSX

Business Summary
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. The Cardiovascular segment includes Cardiology and Peripheral Interventions. The Company's Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-YesYesYes-

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2023YesYes-YesYes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, President, Chief Executive Officer Michael F.Mahoney 58 5/1/2016 10/17/2011
Chief Financial Officer, Executive Vice President Daniel J.Brennan 57 1/1/2014 1/1/2014
Executive Vice President - Human Resources WendyCarruthers 54 2/1/2022 12/1/2012
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
BAYLIS MEDICAL UK LIMITED NEW PENDEREL HOUSE, 4TH FLOOR 283-288 HIGH HOLBORN UK
Symetis SA Chemin de la venoge 11 ECUBLENS Switzerland
American Medical Systems Europe B.V. Vestastraat 6 KERKRADE Netherlands
38 additional Subsidiary records available in full report.

Business Names
Business Name
34 Biomedical Merger Corp.
9357-1867 Quebec Inc.
Acotec Scientific Holdings Limited (Cayman Islands)
188 additional Business Names available in full report.

General Information
Number of Employees: 48,000 (As of 12/31/2023)
Outstanding Shares: 1,467,095,627 (As of 1/31/2024)
Shareholders: 5,432
Stock Exchange: NYSE
Federal Tax Id: 042695240
Fax Number: (508) 650-8923


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, March 18, 2024